Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Jaundice

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Portal Hypertension

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...

Genetic Lingo

Genetic Lingo

Disorders of Erythrocytes

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

Multiple Allele Traits

Multiple Allele Traits

The Concept of Multiple Allelism

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

MMW Fortschritte der Medizin·2025

Same author

MMW Fortschritte der Medizin·2024

Same author

MMW Fortschritte der Medizin·2024

Same author

Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.

American journal of hematology·2024

Same author

[Liver disease associated with alpha1 antitrypsin deficiency].

MMW Fortschritte der Medizin·2024

Same author

Management, vaccination status and COVID-19 morbidity of patients with Gaucher disease in Germany during the COVID-19 pandemic.

Zeitschrift fur Gastroenterologie·2023

Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020

Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020

Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020

Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016

Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016

Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2014

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

[Hereditary hemochromatosis].

Claus Niederau¹

¹Katholische Kliniken Oberhausen gGmbH, St Josef-Hospital, Klinik für Innere Medizin, Akademisches Lehrkrankenhaus der Universität Duisburg-Essen, Duisburg-Essen. claus.niederau@st-josef.de

Medizinische Klinik (Munich, Germany : 1983)

|December 30, 2009

Summary

This summary is machine-generated.

Genetic hemochromatosis, primarily Type 1, results from HFE gene mutations causing iron overload. Early diagnosis and phlebotomy treatment are crucial for normal life expectancy and preventing organ damage.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Related Experiment Videos

Last Updated: Jun 17, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Area of Science:

* Genetics and Metabolism
* Gastroenterology and Hepatology

Background:

* Genetic hemochromatosis is a group of inherited disorders characterized by excessive iron absorption.
* Type 1, caused by HFE gene mutations (C282Y), is most common in Caucasians and leads to organ damage.
* Other types (2, 3, 4) involve different genes and inheritance patterns, presenting with varying severity.

Purpose of the Study:

* To review the classification, genetic basis, and clinical significance of different hemochromatosis subtypes.
* To outline diagnostic approaches, including genetic testing and biochemical markers.
* To discuss management strategies and prognosis based on early diagnosis and treatment.

Main Methods:

* Review of existing literature on genetic hemochromatosis subtypes, genetics, diagnosis, and treatment.
* Analysis of diagnostic criteria including serum ferritin, transferrin saturation, and genetic testing (HFE C282Y).
* Evaluation of treatment outcomes, particularly phlebotomy, and associated risks like liver fibrosis and cancer.

Main Results:

* Homozygous C282Y HFE mutation accounts for most Type 1 hemochromatosis cases, leading to iron overload.
* Diagnostic accuracy is high with transferrin saturation, and liver biopsy is often unnecessary for C282Y homozygotes unless ferritin levels are elevated.
* Phlebotomy is effective in managing iron overload and improves life expectancy, especially when initiated early.

Conclusions:

* Early diagnosis of genetic hemochromatosis is paramount for effective management and preventing long-term complications.
* Genetic testing, particularly for the HFE C282Y mutation, aids in early identification.
* Timely phlebotomy treatment significantly improves patient outcomes, including normal life expectancy in noncirrhotic stages.